Prof. Dr. Christoph Schindler (ZKS) at the EWMA Congress 2023

At this year's European Wound Management Association Congress in Milan, Prof. Schindler presented the results of the Aurealis Therapeutics study on AUP-16. In this first-in-human phase 1 clinical trial, the live gene therapy biotherapeutic drug was shown to accelerate the healing of diabetic foot ulcers.